GGrantIndex
Sort

4,870 grants matching glp 1

Intestinal satiation in Roux-en-Y gastric bypass rats: brain mechanisms and sex d

$195,243
Loredana Asarian · University Of Zurich · R01 · FY2013 · DK

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

$195,000
Absalon Dennis Gutierrez · University Of Texas Hlth Sci Ctr Houston · R21 · FY2021 · DK

Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma

$194,995
Dinah Foer · Brigham And Women'S Hospital · K23 · FY2022 · HL

Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma

$194,995
Dinah Foer · Brigham And Women'S Hospital · K23 · FY2025 · HL

Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma

$194,995
Dinah Foer · Brigham And Women'S Hospital · K23 · FY2024 · HL

Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma

$194,995
Dinah Foer · Brigham And Women'S Hospital · K23 · FY2023 · HL

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

$194,792
Absalon Dennis Gutierrez · University Of Texas Hlth Sci Ctr Houston · R21 · FY2020 · DK

CONTROL OF MEIOSIS AND GERMLINE PROLIFERATION

$194,672
Vanderbilt University · R01 · FY2002 · GM

Energy and Appetite Regulation by High and Low CHO Diets

$194,553
Diane D Stadler · Oregon Health & Science University · R21 · FY2008 · AT

Effects of Leptin on Body Weight and Neuroendocrine Axes after Gastric Bypass

$194,385
Judith Korner · Columbia University Health Sciences · R21 · FY2008 · DK

Vector Core

$193,937
Barry J. Byrne · Johns Hopkins University · P01 · FY2009 · HL

Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists

$193,430
Konrad Talbot · Loma Linda University · R01 · FY2020 · AG

Risk Factors and Etiology of Obesity and Type 2 Diabetes

$193,211
Jonathan Krakoff · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

Targeted Nanoparticles of Bismuth Organo Complexes for Spectral CT Imaging of Cor

$193,077
Y Andrew Wang · Ocean Nanotech, Llc · R42 · FY2013 · HL

Bioanalytical Core

$192,992
Pedro A. Jose · Children'S Research Institute · U54 · FY2013 · HD

Modulation of Human Myocardial Metabolism by GLP-1

$192,500
Kieren J Mather · Indiana University Indianapolis · R21 · FY2011 · HL

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

$192,500
Absalon Dennis Gutierrez · University Of Texas Hlth Sci Ctr Houston · R21 · FY2019 · DK

Thiol-Ene Click Hydrogels for in situ Cell Expansion and Differentiation

$192,500
Chien-Chi Lin · Indiana University Indianapolis · R21 · FY2012 · EB

A Novel cutaneous gene therapy for combating alcohol use disorder

$192,375
Ming Xu · University Of Chicago · R21 · FY2019 · AA

Influence of peripheral insulin resistance and hepatic lipogenesis on liver fat in obese PCOS girls

$192,239
Melanie G Cree · University Of Colorado Denver · K23 · FY2017 · DK

Assessing Patient-Centric Factors and Enhancing Risk Communication to Improve Treatment Persistence in Kidney and Cardiovascular Care

$192,215
Jesse Chimezie Ikeme · University Of California, San Francisco · K23 · FY2025 · DK

03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)

$192,155
Marc L Reitman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

$192,031
Kaitlin M Love · University Of Virginia · K23 · FY2024 · DK

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

$192,031
Kaitlin M Love · University Of Virginia · K23 · FY2025 · DK

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

$192,031
Kaitlin M Love · University Of Virginia · K23 · FY2023 · DK